Key stats
About Xtrackers USD Corporate Bond Short Duration SRI PAB UCITS ETF
Home page
Inception date
Nov 6, 2018
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
DWS Investment SA
Identifiers
2
ISIN IE00BFMKQ930
The investment objective of the Fund is to track the performance before fees and expenses of the Underlying Asset, which is the Bloomberg MSCI USD Corporate Sustainable and SRI 0-5 Years Index (the Reference Index).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Corporate
Bonds, Cash & Other100.00%
Corporate99.58%
Mutual fund0.38%
Cash0.04%
Stock breakdown by region
North America84.57%
Europe9.65%
Asia4.70%
Oceania0.97%
Latin America0.10%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
XYLE top holdings are AbbVie Inc. 3.2% 21-NOV-2029 and CVS Health Corporation 4.3% 25-MAR-2028, occupying 0.42% and 0.40% of the portfolio correspondingly.
No, XYLE doesn't pay dividends to its holders.
XYLE shares are issued by Deutsche Bank AG under the brand Xtrackers. The ETF was launched on Nov 6, 2018, and its management style is Passive.
XYLE expense ratio is 0.21% meaning you'd have to pay 0.21% of your investment to help manage the fund.
XYLE follows the Bloomberg MSCI USD Corporate SRI 0-5 Years PAB Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
XYLE invests in bonds.